Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamila Wojas-Krawczyk

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 30, 2011
The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patientsKamila Wojas-Krawczyk, Paweł Krawczyk, Beata Biernacka, et al.
International Journal of Molecular Sciences|September 10, 2021
Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with ImmunotherapyKamila Wojas-Krawczyk, Iwona Paśnik, Tomasz Kucharczyk, et al.
Translational Lung Cancer Research|April 18, 2025
Prognostic significance of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in second-line immunotherapy for patients with non-small cell lung cancerMagdalena Knetki-Wróblewska, Aleksandra Grzywna, Paweł Krawczyk, et al.
Archives of Medical Science : AMS|September 26, 2022
Correlation between <i>KRAS</i>, <i>NRAS</i> and <i>BRAF</i> mutations and tumor localizations in patients with primary and metastatic colorectal cancerAleksandra Bożyk, Paweł Krawczyk, Katarzyna Reszka, et al.
Pathology Oncology Research : POR|May 3, 2014
The application of real-time PCR technique to detect rare cell clones with primary T790M Substitution of EGFR gene in metastases of non-small cell lung cancer to central nervous system in chemotherapy naive patientsTomasz Powrózek, Paweł Krawczyk, Bożena Jarosz, et al.
Brain Pathology (Zurich, Switzerland)|November 24, 2016
Screening for ALK abnormalities in central nervous system metastases of non-small-cell lung cancerMarcin Nicoś, Bożena Jarosz, Paweł Krawczyk, et al.
Tumori|June 26, 2015
Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancerTomasz Powrózek, Paweł Krawczyk, Juliusz Pankowski, et al.
Immunotargets and Therapy|December 25, 2025
Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A ReviewKamil Kośmider, Agata Kozakiewicz, Paweł Krawczyk, et al.
Pathology Oncology Research : POR|December 19, 2016
Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung CancerMichał Szczyrek, Radosław Mlak, Paweł Krawczyk, et al.
Pneumonologia I Alergologia Polska|August 19, 2014
Methodological recommendations for the diagnostics of EGFR gene mutations and ALK gene rearrangement in the selection of non-small-cell lung cancer patients to molecularly targeted therapiesPaweł Krawczyk, Joanna Chorostowska-Wynimko, Rafał Dziadziuszko, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 30, 2011
The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patientsKamila Wojas-Krawczyk, Paweł Krawczyk, Beata Biernacka, et al.
International Journal of Molecular Sciences|September 10, 2021
Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with ImmunotherapyKamila Wojas-Krawczyk, Iwona Paśnik, Tomasz Kucharczyk, et al.
Translational Lung Cancer Research|April 18, 2025
Prognostic significance of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in second-line immunotherapy for patients with non-small cell lung cancerMagdalena Knetki-Wróblewska, Aleksandra Grzywna, Paweł Krawczyk, et al.
Archives of Medical Science : AMS|September 26, 2022
Correlation between <i>KRAS</i>, <i>NRAS</i> and <i>BRAF</i> mutations and tumor localizations in patients with primary and metastatic colorectal cancerAleksandra Bożyk, Paweł Krawczyk, Katarzyna Reszka, et al.
Pathology Oncology Research : POR|May 3, 2014
The application of real-time PCR technique to detect rare cell clones with primary T790M Substitution of EGFR gene in metastases of non-small cell lung cancer to central nervous system in chemotherapy naive patientsTomasz Powrózek, Paweł Krawczyk, Bożena Jarosz, et al.
Brain Pathology (Zurich, Switzerland)|November 24, 2016
Screening for ALK abnormalities in central nervous system metastases of non-small-cell lung cancerMarcin Nicoś, Bożena Jarosz, Paweł Krawczyk, et al.
Tumori|June 26, 2015
Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancerTomasz Powrózek, Paweł Krawczyk, Juliusz Pankowski, et al.
Immunotargets and Therapy|December 25, 2025
Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A ReviewKamil Kośmider, Agata Kozakiewicz, Paweł Krawczyk, et al.
Pathology Oncology Research : POR|December 19, 2016
Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung CancerMichał Szczyrek, Radosław Mlak, Paweł Krawczyk, et al.
Pneumonologia I Alergologia Polska|August 19, 2014
Methodological recommendations for the diagnostics of EGFR gene mutations and ALK gene rearrangement in the selection of non-small-cell lung cancer patients to molecularly targeted therapiesPaweł Krawczyk, Joanna Chorostowska-Wynimko, Rafał Dziadziuszko, et al.
Pageof 7